Imlunestrant

Cat. No.: IBDI-438123

Imlunestrant (LY-3484356) is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant can be used for the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC).

Product Details

Target	Estrogen Receptor/ERR
Molecular Weight	524.51
Synonyms	LY-3484356
SMILES	OC1=CC2=NC=C(C3=CC=C(C(F)(F)F)C=C3O[[email protected]]4([H])C5=CC=C(C=C5)OCCN6CC(C6)CF)C4=C2C=C1

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.